sleep apnea and glp 1 Efficacy of GLP-1 Receptor agonists in treating Obstructive apnea: A systematic review meta-analysis of cardiometabolic and respiratory outcomes GLP-1 For Sleep Apnea -

REDUCE HUNGER & CRAVINGS: Patented and clinically-studied Supresa saffron extract is shown to reduce hunger and snacking in as early as 8 weeks in clinical study participants. SUPPORT WEIGHT MANAGEMENT: Clinically-tested Morosil red orange extract is shown to support fat reduction, reduce BMI and combat visceral fat (in combination with diet and exercise) in clinical study participants. The product is formulated to support healthy weight management

IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RA) are novel agents with proven cardiovascular (CV) benefits

Compounders were expected to cease production of tirzepatide by March 2025 and semaglutide by May 2025, yet both remain active in the market

GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure

Two recent studies suggest that treating obesity and metabolic dysfunction with GLP-1 drugs could help restore hormonal balance and reproductive function in both women and men.

Keep an open mind, but not so open that your brains fall out. Richard P